21:05 , Jul 18, 2017 |  BC Innovations  |  Distillery Techniques

Disease models

TECHNOLOGY: 3-D models hPSC-derived lung bud organoids could be used to model pulmonary diseases. The organoids are generated by differentiating adherent hPSCs into anterior foregut endoderm by suspending detached clumps of the cells in a...
08:00 , Feb 7, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Hepatic disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Hepatic disease Liver disease Fibroblast growth factor 7 (FGF7) Mouse studies suggest FGF7 could help activate liver progenitor cells (LPCs) to treat...
07:00 , Sep 17, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Pulmonary disease

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Pulmonary disease Acute lung injury Fibroblast growth factor 7 (FGF7; KGF) Ex vivo studies of human lungs suggest that allogeneic mesenchymal stem cells (MSCs) could...